GeneDx Holdings Corp.
WGSNASDAQHealthcare● Active
$54.20
+$2.40(+4.63%)
Market Cap$1.6B
P/E Ratio—
52W High$170.87
52W Low$32.21
GeneDx Holdings Corp. (WGS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · WGS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.43B | $0.31B | $0.20B | $0.23B | $0.21B |
| Cost of Revenue | $0.13B | $0.11B | $0.11B | $0.26B | $0.23B |
| Gross Profit | $0.30B | $0.19B | $0.09B | ($0.03B) | ($0.02B) |
| Gross Margin %(computed) | 69.74% | 63.64% | 44.43% | -11.40% | -7.82% |
| Operating Expenses | |||||
| R&D Expenses | $0.07B | $0.05B | $0.06B | $0.09B | $0.11B |
| G&A Expenses | $0.15B | $0.10B | $0.13B | $0.22B | $0.21B |
| Total Operating Expenses | $0.31B | $0.22B | $0.27B | $0.64B | $0.43B |
| Operating Income | ($0.01B) | ($0.02B) | ($0.18B) | ($0.67B) | ($0.45B) |
| Operating Margin %(computed) | -2.76% | -7.60% | -89.15% | -284.48% | -210.25% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.05B) | ($0.18B) | ($0.60B) | ($0.25B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) | ($0.05B) | $0.00B |
| Net Income | ($0.02B) | ($0.05B) | ($0.18B) | ($0.55B) | ($0.25B) |
| Net Margin %(computed) | -4.92% | -17.12% | -86.77% | -233.91% | -115.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.73 | $-1.94 | $-7.23 | $-53.63 | $-74.93 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.02B | 0.01B | 0.00B |
| EBITDA | $0.01B | ($0.00B) | ($0.14B) | ($0.40B) | ($0.22B) |
| EBITDA Margin %(computed) | 1.55% | -0.41% | -67.37% | -169.67% | -104.03% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more GeneDx Holdings Corp. data
About GeneDx Holdings Corp. (WGS) Income Statement
GeneDx Holdings Corp. (WGS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, WGS reported revenue of $0.43B, gross profit of $0.30B (gross margin 69.74%), and net income of ($0.02B) — a net profit margin of -4.92%.
Frequently asked questions
WGS · 4 questionsGeneDx Holdings Corp. (WGS) reported revenue of $0.43B for 2025, up 40.0% year-over-year.
WGS revenueWGS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09